In summary, we have described the use of NGS coupled with protein structural analysis to identify apparently disease‐causing variants in POLRMT and shown several different clinical presentations associated with these variants, highlighting the wide clinical and genetic spectrum of POLRMT‐related mitochondrial disease. The gene discussed is POLRMT; the disease is inborn mitochondrial metabolism disorder.